Global Health Drug Discovery Institute
Global Health Drug Discovery Institute | 全球健康药物研发中心
Beijing, China
Member since 2019
Representative
Rumin Zhang, Ph.D., Chief Scientific Officer
Team
- Shuo Chen
- Renhe Liu
- E. Liang
- Qian Zhao
- Liangliang Zhou
References
- Xu, J.; Converse, P. J.; Upton, A. M.; Mdluli, K.; Fotouhi, N.; Nuermberger, E. L. Comparative Efficacy of the Novel Diarylquinoline TBAJ-587 and Bedaquiline against a Resistant Rv0678 Mutant in a Mouse Model of Tuberculosis. Antimicrobial Agents and Chemotherapy 2021, 65 (4). https://doi.org/10.1128/AAC.02418-20.
- Yang, Y.; Xu, Y.; Yue, Y.; Wang, H.; Cui, Y.; Pan, M.; Zhang, X.; Zhang, L.; Li, H.; Xu, M.; Tang, Y.; Chen, S. Investigate Natural Product Indolmycin and the Synthetically Improved Analogue Toward Antimycobacterial Agents. ACS Chemical Biology 2022, 17 (1), 39–53. https://doi.org/10.1021/ACSCHEMBIO.1C00394.